Robert Langer

Robert Langer
Name	Robert Langer
Caption	Robert Langer at the Massachusetts Institute of Technology
Birth date	29 August 1948
Birth place	Albany, New York, U.S.
Fields	Chemical engineering, Biomedical engineering, Biotechnology
Workplaces	Massachusetts Institute of Technology
Alma mater	Cornell University (B.S.), Massachusetts Institute of Technology (Sc.D.)
Known for	Controlled drug delivery, Tissue engineering, Angiogenesis inhibitors
Awards	National Medal of Science (2006), National Medal of Technology and Innovation (2011), Queen Elizabeth Prize for Engineering (2015), Breakthrough Prize in Life Sciences (2014), Charles Stark Draper Prize (2002), Wolf Prize in Chemistry (2013)

Robert Langer. He is an American chemical engineer, scientist, and entrepreneur widely regarded as a pioneer in the fields of biomedical engineering and biotechnology. A professor at the Massachusetts Institute of Technology, his groundbreaking work on controlled drug delivery systems and tissue engineering has revolutionized modern medicine. Langer holds over 1,400 patents, which have been licensed or sublicensed to hundreds of pharmaceutical, chemical, biotechnology, and medical device companies, and his research has impacted the lives of billions of people worldwide.

Early life and education

Born in Albany, New York, he demonstrated an early aptitude for science and mathematics. He pursued his undergraduate studies at Cornell University, where he earned a Bachelor of Science degree in chemical engineering. Following his graduation, Langer continued his academic journey at the Massachusetts Institute of Technology, obtaining a Doctor of Science degree in the same field. His doctoral research, conducted under the guidance of Clark K. Colton, focused on enzyme kinetics and laid the foundation for his interdisciplinary approach to solving medical problems.

Academic career and research

After completing his doctorate, Langer conducted postdoctoral work in the laboratory of Judah Folkman at Boston Children's Hospital, a pivotal experience that directed his focus toward medicine. In 1978, he joined the faculty of the Massachusetts Institute of Technology, where he is currently the David H. Koch Institute Professor. His laboratory at the Koch Institute for Integrative Cancer Research is one of the largest academic biomedical engineering labs in the world, focusing on the interface of materials science and medicine. His research spans a vast array of topics, including polymer science, nanotechnology, and regenerative medicine.

Major scientific contributions

Langer's most celebrated contribution is the development of the first controlled-release systems for macromolecules, which enabled the steady, long-term delivery of large-molecule drugs like proteins and peptides. This work led to technologies such as the Gliadel wafer for treating brain cancer. He also pioneered the field of tissue engineering, creating some of the first successful examples of lab-grown tissues using biodegradable polymer scaffolds. Furthermore, his research on angiogenesis inhibitors provided critical insights into blocking blood vessel growth to starve tumors, influencing the development of drugs like Avastin. His work in transdermal drug delivery has also advanced novel vaccine and drug administration methods.

Awards and honors

Langer is one of the most highly decorated engineers and scientists in history. He is one of very few individuals to have received both the National Medal of Science and the National Medal of Technology and Innovation. His other prestigious awards include the Queen Elizabeth Prize for Engineering, the Breakthrough Prize in Life Sciences, the Charles Stark Draper Prize, and the Wolf Prize in Chemistry. He is a member of all three major United States national academies: the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine. He has also received the prestigious Japan Prize.

Entrepreneurship and biotechnology ventures

A prolific entrepreneur, Langer has co-founded over 40 biotechnology companies based on technologies developed in his lab. These ventures have played a major role in translating academic research into real-world therapies and products. Notable companies he helped launch include Moderna, a pioneer in messenger RNA therapeutics; Momenta Pharmaceuticals, focused on complex drugs; and BIND Biosciences, which developed targeted nanoparticles. His entrepreneurial activities have significantly shaped the biotechnology industry in Cambridge, Massachusetts, and globally, bringing numerous drugs and medical devices to market.

Personal life and legacy

Langer is married and has three children. He is known for his mentorship, having trained hundreds of students and postdoctoral fellows who have gone on to become leaders in academia, industry, and medicine. His legacy extends beyond his own inventions to the vast ecosystem of scientists, engineers, and companies he has inspired. Through his foundational research, prolific innovation, and successful commercialization, he has established a new paradigm for applying engineering principles to solve some of medicine's most intractable challenges, profoundly impacting global health.

Category:American chemical engineers Category:Massachusetts Institute of Technology faculty Category:National Medal of Science recipients Category:National Medal of Technology and Innovation recipients